Apr 29, 2022 07:50AM

Apr 29, 2022 02:46AM

Apr 28, 2022 10:13AM

Apr 7, 2022 06:08AM

Apr 6, 2022 08:48AM

Apr 6, 2022 04:00AM

Apr 4, 2022 01:44PM Correction: Proposal for a statutory restructuring plan

Mar 31, 2022 05:36PM

Mar 31, 2022 12:00PM

Mar 29, 2022 07:15AM

Mar 22, 2022 06:54AM

Mar 18, 2022 06:40AM

Mar 10, 2022 04:09PM

Mar 10, 2022 04:05PM Commencement of in-court restructuring of Orphazyme A/S

Mar 3, 2022 03:35AM

Feb 28, 2022 02:25AM

Feb 24, 2022 08:00AM

Feb 23, 2022 04:32PM

Feb 23, 2022 04:05PM

Feb 18, 2022 04:01PM

Feb 15, 2022 12:15PM Resolutions passed at the Extraordinary General Meeting

Feb 14, 2022 04:01PM

Feb 14, 2022 08:00AM

Feb 1, 2022 05:30AM

Jan 31, 2022 11:00AM

Jan 24, 2022 04:15PM

Jan 18, 2022 04:15PM

Nov 12, 2021 08:00AM CytRx Comments on Quarterly Results and Recent Strategic Initiatives

Nov 2, 2021 08:00AM

Oct 31, 2021 04:00PM

Oct 7, 2021 02:40AM

Oct 5, 2021 02:55AM

Sep 7, 2021 09:42AM

Aug 31, 2021 01:00AM

Aug 25, 2021 08:36PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orphazyme, CorMedix, Koninklijke Philips, and Sesen Bio and Encourages Investors to Contact the Firm

Aug 24, 2021 08:00AM

Aug 18, 2021 08:00PM

Aug 12, 2021 04:06PM

Aug 11, 2021 08:00PM

Aug 10, 2021 11:30AM

Aug 5, 2021 06:54PM

Aug 4, 2021 08:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm

Jul 29, 2021 08:00AM

Jul 28, 2021 09:37PM

Jul 21, 2021 08:00PM

Jul 16, 2021 08:00AM

Jul 14, 2021 09:00PM

Jul 13, 2021 08:00AM

Jun 30, 2021 08:00AM CytRx Comments on Orphazyme’s Promising 24-Month Interim Trial Results of Arimoclomol for Niemann-Pick Disease Type C

Jun 28, 2021 06:18AM

324,655 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All